rolipram has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamamoto, M | 1 |
| Suga, M | 1 |
| Takahashi, Y | 1 |
| Sato, Y | 1 |
| Inamori, S | 1 |
| Yagihara, T | 1 |
| Nakatani, T | 1 |
| Kitamura, S | 1 |
1 other study available for rolipram and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Suppressive effect of phosphodiesterase type 4 inhibition on systemic inflammatory responses after cardiopulmonary bypass.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiopulmonary Bypass; CD11b Antigen; Cyclic Nucleoti | 2006 |